Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

NCT00725803 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV Infection

Interventions

DRUG: GS-9450
DRUG: GS-9450 Placebo

Sponsor

Gilead Sciences